141 related articles for article (PubMed ID: 36575285)
1. Frequency of thoracic recurrence based on pathological features in patients with ovarian epithelial tumors in stage I versus higher stages.
Matsutani H; Nakai G; Fujiwara S; Takahashi S; Yamamoto K; Ohmichi M; Osuga K
Jpn J Radiol; 2023 May; 41(5):500-509. PubMed ID: 36575285
[TBL] [Abstract][Full Text] [Related]
2. A recurrence-predicting prognostic factor for patients with ovarian clear-cell adenocarcinoma at reproductive age.
Kajiyama H; Mizuno M; Shibata K; Umezu T; Suzuki S; Yamamoto E; Mitsui H; Sekiya R; Niimi K; Kawai M; Nagasaka T; Kikkawa F
Int J Clin Oncol; 2014 Oct; 19(5):921-7. PubMed ID: 24306200
[TBL] [Abstract][Full Text] [Related]
3. The role of serum CA-125 levels and CA-125 tissue expression positivity in the prediction of the recurrence of stage III and IV epithelial ovarian tumors (CA-125 levels and tissue CA-125 in ovarian tumors).
Gundogdu F; Soylu F; Erkan L; Tatli O; Mavi S; Yavuzcan A
Arch Gynecol Obstet; 2011 Jun; 283(6):1397-402. PubMed ID: 20645105
[TBL] [Abstract][Full Text] [Related]
4. Patterns of Recurrence and Clinical Outcome of Patients With Stage IIIC to Stage IV Epithelial Ovarian Cancer in Complete Response After Primary Debulking Surgery Plus Chemotherapy or Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery: An Italian Multicenter Retrospective Study.
Gadducci A; Cosio S; Zizioli V; Notaro S; Tana R; Panattoni A; Sartori E
Int J Gynecol Cancer; 2017 Jan; 27(1):28-36. PubMed ID: 27870700
[TBL] [Abstract][Full Text] [Related]
5. Abdominopelvic cytoreduction rates and recurrence sites in stage IV ovarian cancer: is there a case for thoracic cytoreduction?
Perri T; Ben-Baruch G; Kalfon S; Beiner ME; Helpman L; Hogen LB; Shapira-Frommer R; Korach J
Gynecol Oncol; 2013 Oct; 131(1):27-31. PubMed ID: 23880152
[TBL] [Abstract][Full Text] [Related]
6. Residual tumor after the salvage surgery is the major risk factors for primary treatment failure in malignant ovarian germ cell tumors: a retrospective study of single institution.
Lee CW; Song MJ; Park ST; Ki EY; Lee SJ; Lee KH; Ryu KS; Park JS; Hur SY
World J Surg Oncol; 2011 Oct; 9():123. PubMed ID: 21988930
[TBL] [Abstract][Full Text] [Related]
7. Timing and patterns of recurrence in epithelial ovarian cancer patients with no gross residual disease after primary debulking surgery.
Paik ES; Lee YY; Shim M; Choi HJ; Kim TJ; Choi CH; Lee JW; Kim BG; Bae DS
Aust N Z J Obstet Gynaecol; 2016 Dec; 56(6):639-647. PubMed ID: 27611447
[TBL] [Abstract][Full Text] [Related]
8. Oncologic outcome after recurrence in patients with stage I epithelial ovarian cancer: are clear-cell and mucinous histological types a different entities?
Kajiyama H; Mizuno M; Shibata K; Umezu T; Suzuki S; Yamamoto E; Mitsui H; Sekiya R; Niimi K; Kawai M; Nagasaka T; Kikkawa F
Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():305-10. PubMed ID: 25203309
[TBL] [Abstract][Full Text] [Related]
9. Comparison of survival outcomes after recurrence detected by cancer antigen 125 elevation versus imaging study in epithelial ovarian cancer.
Paik ES; Kim TJ; Lee YY; Choi CH; Lee JW; Kim BG; Bae DS
J Gynecol Oncol; 2016 Sep; 27(5):e46. PubMed ID: 27329194
[TBL] [Abstract][Full Text] [Related]
10. Long-term oncologic outcome and its prognostic indicators in reproductive-age women with ovarian clear-cell carcinoma.
Kajiyama H; Suzuki S; Yoshikawa N; Niimi K; Kawai M; Shibata K; Kikkawa F
Arch Gynecol Obstet; 2019 Sep; 300(3):717-724. PubMed ID: 31165243
[TBL] [Abstract][Full Text] [Related]
11. Nomogram to predict recurrence in patients with early- and advanced-stage mucinous and serous borderline ovarian tumors.
Bendifallah S; Ballester M; Uzan C; Fauvet R; Morice P; Darai E
Am J Obstet Gynecol; 2014 Dec; 211(6):637.e1-6. PubMed ID: 24949545
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of laparoscopic fertility-sparing surgery in clinically early-stage epithelial ovarian cancer.
Park JY; Heo EJ; Lee JW; Lee YY; Kim TJ; Kim BG; Bae DS
J Gynecol Oncol; 2016 Mar; 27(2):e20. PubMed ID: 26768783
[TBL] [Abstract][Full Text] [Related]
13. Preoperative 18F-FDG PET/CT in the management of advanced epithelial ovarian cancer.
Fruscio R; Sina F; Dolci C; Signorelli M; Crivellaro C; Dell'Anna T; Cuzzocrea M; Guerra L; Milani R; Messa C
Gynecol Oncol; 2013 Dec; 131(3):689-93. PubMed ID: 24076062
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of patients with an isolated ovarian recurrence after conservative treatment of epithelial ovarian cancer: review of the results of an international multicenter study comprising 545 patients.
Bentivegna E; Fruscio R; Roussin S; Ceppi L; Satoh T; Kajiyama H; Uzan C; Colombo N; Gouy S; Morice P
Fertil Steril; 2015 Nov; 104(5):1319-24. PubMed ID: 26149354
[TBL] [Abstract][Full Text] [Related]
15. Ovarian sarcoma carries a poorer prognosis than ovarian epithelial cancer throughout all FIGO stages: a single-center case-control matched study.
Bacalbasa N; Balescu I; Dima S; Popescu I
Anticancer Res; 2014 Dec; 34(12):7303-8. PubMed ID: 25503164
[TBL] [Abstract][Full Text] [Related]
16. Validation of Revised FIGO Staging Classification for Cancer of the Ovary, Fallopian Tube, and Peritoneum Based on a Single Histological Type.
Toptas T; Pestereli E; Erol O; Bozkurt S; Erdogan G; Simsek T
Int J Gynecol Cancer; 2016 Jul; 26(6):1012-9. PubMed ID: 27206284
[TBL] [Abstract][Full Text] [Related]
17. Platinum-based adjuvant chemotherapy on moderate- and high-risk stage I and II epithelian ovarian cancer patients. Long-term single institution experience and literature review.
García-Sáenz JA; Custodio A; Casado A; Vidart JA; Coronado PJ; Martín M; López-Tarruella S; Puente J; Fernández C; Díaz-Rubio E
Clin Transl Oncol; 2011 Feb; 13(2):121-32. PubMed ID: 21324801
[TBL] [Abstract][Full Text] [Related]
18. Fertility sparing surgery in early stage epithelial ovarian cancer.
Ditto A; Martinelli F; Lorusso D; Haeusler E; Carcangiu M; Raspagliesi F
J Gynecol Oncol; 2014 Oct; 25(4):320-7. PubMed ID: 25142621
[TBL] [Abstract][Full Text] [Related]
19. Cervical carcinoma with glandular differentiation: histological evaluation predicts disease recurrence in clinical stage I or II patients.
Costa MJ; McIlnay KR; Trelford J
Hum Pathol; 1995 Aug; 26(8):829-37. PubMed ID: 7635446
[TBL] [Abstract][Full Text] [Related]
20. Correlation of pre-operative CT findings with surgical & histological tumor dissemination patterns at cytoreduction for primary advanced and relapsed epithelial ovarian cancer: A retrospective evaluation.
Nasser S; Lazaridis A; Evangelou M; Jones B; Nixon K; Kyrgiou M; Gabra H; Rockall A; Fotopoulou C
Gynecol Oncol; 2016 Nov; 143(2):264-269. PubMed ID: 27586894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
